HOLDREGE — A $70 million expansion project for Becton, Dickinson and Company in Nebraska will support U.S. vaccination efforts during the pandemic. BD recently announced a partnership with the ...
DUBLIN--(BUSINESS WIRE)--The "Europe Syringes & Needles Market - Focused Insights 2023-2028" report has been added to ResearchAndMarkets.com's offering. In 2022, Europe Syringes and Needles market was ...
LE PONT-DE-CLAIX, France, Sept. 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™ ...
Becton Dickinson masterminded the prefillable syringe, and decades later, it's a technology key to the global COVID-19 vaccine rollout. And with pandemic demand surging, BD is planning to shell out $1 ...
BD, a leading global medical technology company, is investing more than $35 million to expand prefilled flush syringe manufacturing at its Columbus, Neb., facility. With the investment, the company ...
FRANKLIN LAKES, N.J., Nov. 30, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the U.S.
BD has turned to Mitsubishi Gas Chemical (MGC) to look into ways to improve the delivery of biologics, signing a letter of intent that positions it to assess its partner’s alternative to glass for ...
BD (NYSE:BDX) announced Thursday that the company has increased its domestic manufacturing of syringes after the FDA warned about quality issues linked to plastic syringes made in China. Since the FDA ...
The FDA last week re-upped its recommendations that healthcare providers avoid using plastic syringes made in China wherever possible, while it continues to investigate growing quality concerns. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback